Unknown

Dataset Information

Exploring the efficacy of tumor electric field therapy against glioblastoma: An in vivo and in vitro study.


ABSTRACT:

Aims

Tumor electric fields therapy (TTFields) is emerging as a novel anti-cancer physiotherapy. Despite recent breakthroughs of TTFields in glioma treatment, the average survival time for glioblastoma patients with TTFields is <2 years, even when used in conjugation with traditional anti-cancer therapies. To optimize TTFields-afforded efficacy against glioblastoma, we investigated the cancer cell-killing effects of various TTFields paradigms using in vitro and in vivo models of glioblastoma.

Methods

For in vitro studies, the U251 glioma cell line or primary cell cultures prepared from 20 glioblastoma patients were treated with the tumor electric field treatment (TEFT) system. Cell number, volume, and proliferation were measured after TEFT at different frequencies (100, 150,

SUBMITTER: Wu H 

PROVIDER: S-EPMC8611775 | biostudies-literature | 2021 Dec

REPOSITORIES: biostudies-literature